Protein Tyrosine Kinase
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 24010 | Zasocitinib | 2272904-53-5 | ≧98.0% |  |
| Zasocitinib is under development for the treatment of moderate to severe plaque psori | ||||
| 24011 | Zongertinib | 2728667-27-2 | ≧98.0% |  |
| Zongertinib [BI 1810631] is a human epidermal growth factor receptor 2 (HER2) inhibit | ||||
| 24025 | BIIB-129 | 2770960-52-4 | ≧98.0% |  |
| BIIB129 is a covalent, selective, small molecule inhibitor of Bruton's tyrosine k | ||||
| 25052 | Lazertinib mesylate | 2247995-37-3 | ≧98.0% |  |
| Lazertinib is a an orally available third-generation, selective inhibitor of certain | ||||
| 25089 | Irpagratinib | 2230974-62-4 | ≧98.0% |  |
| Irpagratinib is an orally bioavailable, selective inhibitor of human fibroblast growt | ||||
| 25091 | Rilzabrutinib ( PRN1008 ) | 1575591-66-0 | ≧98.0% | _1575591-66-0.png) |
| Rilzabrutinib ( PRN1008 ) is an oral, reversible, covalent, small-molecule inhibitor | ||||